Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators
The available medications for the treatment of major depressive disorder have limitations, particularly their limited efficacy, delayed therapeutic effects, and the side effects associated with treatment. These issues highlight the need for better therapeutic agents that provide more efficacious and...
Main Authors: | Anderson Camargo, Ana Lúcia S. Rodrigues |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-06-01
|
Series: | Chronic Stress |
Online Access: | https://doi.org/10.1177/2470547019858083 |
Similar Items
-
Distinct symptom-specific treatment targets for antidepressant neuromodulation
by: S. Siddiqi, et al.
Published: (2019-03-01) -
Response to ‘Cerebellum as a possible target for neuromodulation after stroke’
by: Gavin J.B. Elias, et al.
Published: (2018-11-01) -
Cerebellum as a possible target for neuromodulation after stroke
by: Carina França, et al.
Published: (2018-09-01) -
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
by: Caroline Ann Browne, et al.
Published: (2013-12-01) -
Open questions on the mechanisms of neuromodulation with applied and endogenous electric fields
by: Shennan Aibel Weiss, et al.
Published: (2014-04-01)